Home › Heart Failure › Florida › Ocala
Heart Failure clinical trials in Ocala, FL
5 studies for Heart Failure are looking for participants at sites in and around Ocala (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
RecruitingPhase 3
- Research Site, Ocala
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
RecruitingPhase 3
- Ocala Cardiovascular Research, Ocala
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
RecruitingPhase 3
- Ocala Cardiovascular Research, Ocala
- Ocala Research Institute, Inc, Ocala
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
RecruitingPhase 3
- Ocala Cardiovascular Research, Ocala
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
RecruitingPhase 3
- Ocala Cardiovascular Research, Ocala
About Heart Failure
Heart failure, or congestive heart failure (CHF), means the heart can't pump enough blood. Learn about the signs, symptoms, and causes.
More about Heart Failure on MedlinePlus
Heart Failure trials in other cities
- New York City, NY50 studies
- Dallas, TX43 studies
- Boston, MA43 studies
- Houston, TX36 studies
- Cleveland, OH33 studies
- Chicago, IL32 studies
- Philadelphia, PA31 studies
- San Francisco, CA29 studies
- St. Louis, MO26 studies
- Durham, NC26 studies
- Kansas City, MO25 studies
- Atlanta, GA25 studies
Other studies in Ocala
- Non-Small Cell Lung Cancer10 studies
- Obesity7 studies
- Steatotic Liver Disease7 studies
- Alzheimer's Disease6 studies
- Overweight6 studies
- COPD5 studies
- Metastatic Cancer3 studies
- Mild Cognitive Impairment3 studies
- Chronic Pain3 studies
- Atherosclerosis3 studies
- Cardiovascular Disease3 studies
- Liver Diseases3 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.